1. 球脊髄性筋萎縮症 [臨床試験数:17,薬物数:16(DrugBank:8),標的遺伝子数:10,標的パスウェイ数:15

Searched query = "Spinal and bulbar muscular atrophy", "Spinobulbar muscular atrophy", "SBMA", "Kennedy disease", "Kennedy-Alter-Sung syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2010-022558-18-IT11/10/201028/09/2012A pilot trial with clenbuterol in spinal and bulbar muscular atrophy (SBMA).A pilot trial with clenbuterol in spinal and bulbar muscular atrophy (SBMA). spinal and bulbar muscular atrophy (SBMA)
MedDRA version: 15.0Level: HLGTClassification code 10029317Term: Neuromuscular disordersSystem Organ Class: 10029205 - Nervous system disorders
MedDRA version: 15.0Level: SOCClassification code 10029205Term: Nervous system disordersSystem Organ Class: 10029205 - Nervous system disorders
MedDRA version: 15.0Level: LLTClassification code 10047868Term: Weakness of limbsSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disorders
MedDRA version: 15.0Level: PTClassification code 10013969Term: Dyspnoea at restSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disorders;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
Trade Name: MONORES*30CPR 20MCG
INN or Proposed INN: Clenbuterol
AZIENDA OSPEDALIERA DI PADOVANULLAuthorised-recruitment may be ongoing or finishedFemale: no
Male: yes
Italy